We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.2B
AUM Growth
+$4.78B
Cap. Flow
+$3.57B
Cap. Flow %
23.39%
Top 10 Hldgs %
44.86%
Holding
2,187
New
553
Increased
436
Reduced
404
Closed
789

Top Sells

Rank Stock Value
1
VMW
VMware, Inc
VMW
+$95.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$89.4M
3
XOM icon
ExxonMobil
XOM
+$84.7M
4
SO icon
Southern Company
SO
+$79.2M
5
EMR icon
Emerson Electric
EMR
+$61.3M

Sector Composition

Rank Sector Weight
1 Technology 9.26%
2 Industrials 7.84%
3 Utilities 7.6%
4 Healthcare 5.4%
5 Real Estate 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRO icon
201
Brown & Brown
BRO
$24.4B
$10.5M 0.07%
148,175
+130,390
+733% +$9.32M
P
202
Everpure Inc
P
$36.1B
$10.5M 0.07%
295,309
+16,447
+6% +$577K
XPRO icon
203
Expro Ltd
XPRO
$2.05B
$10.5M 0.07%
658,171
+74,819
+13% +$1.29M
PVH icon
204
PVH
PVH
$3.62B
$10.4M 0.07%
+85,235
New +$7.63M
WSR
205
DELISTED
Whitestone REIT
WSR
$10.2M 0.07%
+831,769
New +$8.91M
ALGM icon
206
Allegro MicroSystems
ALGM
$6.93B
$10M 0.07%
331,123
+229,146
+225% +$6.54M
ERIC icon
207
Ericsson
ERIC
$33.5B
$9.86M 0.06%
1,565,500
+646,209
+70% +$3.28M
TECH icon
208
Bio-Techne
TECH
$11.3B
$9.76M 0.06%
126,506
+72,289
+133% +$4.76M
XHB icon
209
PUT
State Street SPDR S&P Homebuilders ETF
XHB
$1.46B
$9.56M 0.06%
100,000
+50,000
+100% +$4.06M
WHD icon
210
Cactus
WHD
$5.57B
$9.53M 0.06%
209,822
-101,364
-33% -$4.61M
MUSA icon
211
Murphy USA
MUSA
$10.5B
$9.44M 0.06%
26,485
+24,358
+1,145% +$8.82M
AVTR icon
212
Avantor
AVTR
$9.78B
$9.42M 0.06%
412,679
-414,341
-50% -$8.49M
SNPS icon
213
Synopsys
SNPS
$76.2B
$9.42M 0.06%
+18,297
New +$9.36M
BURL icon
214
Burlington
BURL
$20.6B
$9.37M 0.06%
48,170
+42,239
+712% +$6.3M
NARI
215
DELISTED
Inari Medical, Inc. Common Stock
NARI
$9.28M 0.06%
142,878
+59,478
+71% +$3.58M
RIVN icon
216
Rivian
RIVN
$24.6B
$9.24M 0.06%
393,816
+364,324
+1,235% +$6.85M
ACM icon
217
Aecom
ACM
$8.34B
$9.24M 0.06%
99,925
+84,215
+536% +$7.15M
CRL icon
218
Charles River Laboratories
CRL
$14.1B
$9.18M 0.06%
38,838
-26,296
-40% -$5.17M
KEYS icon
219
Keysight
KEYS
$53.8B
$9.04M 0.06%
56,803
+24,110
+74% +$3.27M
SJM icon
220
J.M. Smucker
SJM
$13.3B
$9.03M 0.06%
71,418
+52,483
+277% +$6.08M
XP icon
221
XP
XP
$8.53B
$8.89M 0.06%
+340,993
New +$7.78M
PDM
222
Piedmont Realty Trust
PDM
$1.21B
$8.84M 0.06%
1,243,482
+744,601
+149% +$4.5M
OLED icon
223
Universal Display
OLED
$3.95B
$8.84M 0.06%
46,197
-34,763
-43% -$5.75M
GSK icon
224
GSK
GSK
$105B
$8.78M 0.06%
236,809
-62,488
-21% -$2.24M
DHI icon
225
D.R. Horton
DHI
$41.5B
$8.7M 0.06%
57,228
-86,737
-60% -$10.7M

Similar funds

Michael Gelband's Q4 2023 Portfolio in Review

As of Q4 2023, Michael Gelband held 2,187 positions worth $15.2B, up 46% from $10.5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Michael Gelband deployed $3.57B of net new capital in Q4 2023, opening 553 new positions and adding to 436 existing holdings. Its largest new stake was Fidelity National Information Services: 6,650,397 shares worth $399M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 10% a quarter earlier, followed by Industrials and Utilities.

On the sell side, the largest reduction was Merck, an estimated $48.2M trimmed.

  • Michael Gelband's largest Q4 2023 buy was Fidelity National Information Services: 6,650,397 shares worth $399M.
  • Michael Gelband added most to Global Payments in Q4 2023, an estimated $250M increase.
  • Michael Gelband's biggest Q4 2023 reduction was Merck, cutting an estimated $48.2M.
  • Michael Gelband fully exited VMware, Inc in Q4 2023, selling an estimated $95.7M.
  • Michael Gelband's ten largest holdings make up 45% of its $15.2B portfolio in Q4 2023.
  • Michael Gelband opened 553 new positions and closed 789 in Q4 2023.
  • Michael Gelband's portfolio value rose 46% quarter-over-quarter to $15.2B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.